Search results
Viridian Therapeutics (NASDAQ:VRDN) Shares Gap Down to $12.17
ETF DAILY NEWS· 2 days agoViridian Therapeutics, Inc. (NASDAQ:VRDN – Get Free Report)’s share price gapped down before the market opened on Monday . Viridian Therapeutics shares last traded at $11.94, with a volume of ...
Phase 2 Study Shows Opdivo-Yervoy Highly Effective In Colon Cancer
Forbes· 7 days agoA four-week course of dual immunotherapy prior to surgery is highly effective in treating a certain...
MD Anderson Research Highlights: EHA 2024 Special | Newswise
Newswise· 20 hours agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research, and prevention. Thes
US FDA advisers to review Eli Lilly Alzheimer's drug
Reuters· 4 days agoBoth drugs are designed to remove toxic beta amyloid plaques from the brains of people with early Alzheimer's disease. The antibody treatments, which...
Protalix BioTherapeutics to Host In-Person Investor Day to Discuss Current Treatment Landscapes and...
KOLR - KSFX Ozarks· 14 hours agoProtalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by ...
Inebilizumab 'MITIGATES' Flare Risk in IgG4-Related Disease
Medscape· 7 days agoInebilizumab-cdon reduced the risk for flares by 87% in patients with IgG4-RD, the MITIGATE study showed.
GENMAB A/S/S (OTCMKTS:GMXAY) and LianBio (NASDAQ:LIAN) Critical Contrast
ETF DAILY NEWS· 3 days agoLianBio (NASDAQ:LIAN – Get Free Report) and GENMAB A/S/S (OTCMKTS:GMXAY – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses ...
The Ins And Outs Of Modern Barrier Systems For Sterile Manufacturing
BioresearchOnline· 4 days agoBarrier systems include restricted access barrier systems (RABS) and isolators. To prevent direct...
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Insider Thomas Gad Sells 35,000 Shares
ETF DAILY NEWS· 2 days agoY-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Get Free Report) insider Thomas Gad sold 35,000 shares of the stock in a transaction dated Monday, June 10th. The stock was sold at an average price ...
Viridian Therapeutics (NASDAQ:VRDN) Receives Buy Rating from Needham & Company LLC
ETF DAILY NEWS· 2 days agoNeedham & Company LLC reissued their buy rating on shares of Viridian Therapeutics (NASDAQ:VRDN – Free Report) in a research note published on Tuesday morning, Benzinga reports. They currently ...